Advocacy

At PF Warriors, advocacy brings patient and caregiver voices into conversations that shape the future of pulmonary fibrosis. Together, we can raise awareness, improve access to care, and help drive meaningful change.

Below are some of the ways the PF Warriors community is helping make a difference through advocacy.

Pulmonary Fibrosis Community Meets with FDA

In April 2026, the U.S. Food and Drug Administration held a dedicated pulmonary fibrosis patient listening session after Teresa Barnes requested a direct opportunity for patients, caregivers, advocates, and medical experts to share the needs of the pulmonary fibrosis community.

Moderated by Aviva Strategies, the virtual session brought together patients, caregivers, physicians, researchers, and advocates to help FDA staff hear directly from the pulmonary fibrosis community.

Participants shared firsthand perspectives on:

• Living with pulmonary fibrosis day to day
• The urgent need for better treatment options
• Access to clinical trials
• Quality of life and caregiving challenges

This marked the first formal communication between the pulmonary fibrosis community and the FDA since 2014.

 

The page was last reviewed on July 20, 2026